Autoimmune neutropenia

Autoimmune neutropenia (AIN) is a rare disorder characterized by the body's immune system attacking and destroying neutrophils, which are a type of white blood cell essential for fighting off infections. This condition can occur in both adults and children, but it is most commonly observed in infants and young children. The exact cause of AIN is not fully understood, but it is believed to be related to an abnormal immune response.

Etiology

Autoimmune neutropenia can be classified into primary and secondary forms. Primary autoimmune neutropenia is idiopathic, meaning its exact cause is unknown. It is thought to occur when the immune system mistakenly targets neutrophils as foreign and creates antibodies against them. Secondary autoimmune neutropenia is associated with other autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and Crohn's disease, or with certain medications that alter the immune system's function.

Pathophysiology

In autoimmune neutropenia, autoantibodies target and bind to neutrophils. This leads to the premature destruction of these cells by the spleen and other parts of the immune system. The reduction in neutrophil count, known as neutropenia, makes individuals more susceptible to infections.

Clinical Manifestations

The primary symptom of autoimmune neutropenia is an increased susceptibility to infections. These infections are typically mild and may include conditions such as otitis media (middle ear infections), bronchitis, and skin infections. Severe infections are less common but can occur, especially in cases of severe neutropenia.

Diagnosis

Diagnosis of autoimmune neutropenia involves a complete blood count (CBC) to detect neutropenia. Further testing includes specific assays to detect autoantibodies against neutrophils, such as the direct antiglobulin test (DAT) or the neutrophil-specific antibody test.

Treatment

Treatment of autoimmune neutropenia is often supportive and focuses on managing infections. Antibiotics may be used to treat or prevent infections. In cases of severe neutropenia or recurrent infections, granulocyte colony-stimulating factor (G-CSF) may be administered to stimulate the production of neutrophils. In primary autoimmune neutropenia of childhood, the condition often resolves spontaneously within a few years, and treatment may not be necessary.

Prognosis

The prognosis for individuals with autoimmune neutropenia varies. In children with primary autoimmune neutropenia, the condition often resolves on its own without long-term effects. Adults with secondary autoimmune neutropenia have a prognosis that depends on the underlying condition and its management.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian